Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809; Development in Orphan Lung Disease Idiopathic Pulmonary Fibrosis Planned

Pliant Therapeutics Appoints Keith Cummings as Chief Financial Officer and Eduard Gorina as Vice President, Clinical Development

REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019

Sesen Bio Announces Positive Preliminary 12-Month Data from Registration Phase 3 VISTA Trial of Vicinium for Non-Muscle Invasive Bladder Cancer

TARIS Appoints Tony Kingsley as President and Chief Executive Officer